life sciences – Blog WKB 2

Do entities conducting clinical trials definitely need to conclude additional compulsory third-party liability insurance agreements under the recently amended Medical Professions Act?

Aleksandra Bączykowska | Wednesday March 17th, 2021

In our last post on this subject (available at http://ipllectual.pl/pl/nowe-obowiazkowe-ubezpieczenie-udzial-maloletniego-i-przepisy-karne-omowienie-najwazniejszych-zmian-w-przeprowadzaniu-eksperymentow-medycznych/) we gave an overview of the most important changes to the law on conducting...
read more »

New insurance obligations, rules for the participation of minors and penalty regulations – overview of the most important changes in respect of running medical experiments

Agnieszka Wiercińska-Krużewska | 21/01/2021

As of 1 January 2021, changes in the regulations regarding medical experiments, introduced in amendments to the Medical Profession Act, have entered into force. Asa reminder, we would like to point...
read more »

“The only one of its kind on the market, antiviral properties” – advertising medicinal products in the age of the pandemic

Agnieszka Borkowska | 28/05/2020

The advertising of medicinal products is strictly regulated. During a pandemic, responsible entities should take extra care when producing advertising content. It may turn out that previously...
read more »

Do entities conducting clinical trials definitely need to conclude additional compulsory third-party liability insurance agreements under the recently amended Medical Professions Act?

New insurance obligations, rules for the participation of minors and penalty regulations – overview of the most important changes in respect of running medical experiments

“The only one of its kind on the market, antiviral properties” – advertising medicinal products in the age of the pandemic

Categories

Most Popular Tags

Archives